New clinical syndromes under regular intermittent hemodialysis.
D000747:Anemia, Hypochromic / Q000188:drug therapy / Q000209:etiology; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects; D001783:Blood Flow Velocity; D002302:Cardiac Output; D002762:Cholecalciferol / Q000378:metabolism; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D004920:Erythropoiesis; D005947:Glucose / Q000378:metabolism; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D006977:Hypertension, Renal / Q000209:etiology / Q000503:physiopathology; D007248:Infertility, Male / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications* / Q000503:physiopathology; D008297:Male; D010281:Parathyroid Hormone / Q000378:metabolism; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D010710:Phosphates / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*; D014280:Triglycerides / Q000097:blood
D010281:Parathyroid Hormone; D010710:Phosphates; D014280:Triglycerides; D002762:Cholecalciferol; D005947:Glucose